Reuters logo
3 months ago
BRIEF-Horizon Pharma announces U.S. district court's decision to uphold PENNSAID 2% w/w patent
May 15, 2017 / 11:24 AM / 3 months ago

BRIEF-Horizon Pharma announces U.S. district court's decision to uphold PENNSAID 2% w/w patent

May 15 (Reuters) - Horizon Pharma Plc

* Horizon pharma plc says district court decision to uphold pennsaid (diclofenac sodium topical solution) 2% w/w patent Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below